PBH
Prestige Consumer Healthcare Inc

233
Mkt Cap
$2.95B
Volume
578,048.00
52W High
$90.04
52W Low
$59.51
PE Ratio
14.87
PBH Fundamentals
Price
$59.95
Prev Close
$61.36
Open
$61.28
50D MA
$62.97
Beta
0.47
Avg. Volume
372,247.52
EPS (Annual)
$4.29
P/B
1.58
Rev/Employee
$1.9M
Loading...
Loading...
News
all
press releases
Prestige Consumer Healthcare Inc. $PBH Shares Sold by Amica Mutual Insurance Co.
Amica Mutual Insurance Co. cut its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 34.7% during the second quarter, according to its most recent disclosure with the...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Canaccord Genuity Group Has Lowered Expectations for Prestige Consumer Healthcare (NYSE:PBH) Stock Price
Canaccord Genuity Group dropped their price target on shares of Prestige Consumer Healthcare from $100.00 to $88.00 and set a "buy" rating for the company in a research report on Friday...
MarketBeat·14h ago
News Placeholder
Prestige Consumer Healthcare (PBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Prestige Consumer Healthcare (PBH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·3d ago
News Placeholder
Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of +10.31% and +6.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
OraSure Technologies (OSUR) Reports Q3 Loss, Lags Revenue Estimates
OraSure (OSUR) delivered earnings and revenue surprises of +18.75% and -7.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
Earnings Preview: Prestige Consumer Healthcare (PBH) Q2 Earnings Expected to Decline
Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·10d ago
News Placeholder
Implied Volatility Surging for Prestige Consumer Stock Options
Investors need to pay close attention to PBH stock based on the movements in the options market lately.
Zacks·2mo ago
News Placeholder
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·3mo ago
News Placeholder
Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of -5.94% and -4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Stay Ahead of the Game With Prestige Consumer Healthcare (PBH) Q1 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for Prestige Consumer Healthcare (PBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Zacks·3mo ago

Latest PBH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.